| Elevator Pitch |
Novast Pharmaceuticals Ltd., a Chinese generic pharmaceutical maker, recently raised $25 million in Series C funding, according to VentureWire. SAIF Partners led the round. |
| Industry Focus |
BioPharma |
| Category |
Companies - Expansion Stage |
| Location |
Economic Development Zone |
|
1088 80B Avenue |
|
Nantong, Jiangsu
226009
|
|
China |
| |
| Phone |
0513-359-0303 |
| Email |
Please log in |
| Web |
http://www.novast.com |
|
|
|
Amount: $25,000,000
Closed: July 2, 2009
|
|
|
|
|
|
|
Round: Unspecified
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Unspecified
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Unspecified
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Unspecified
Amount: Unspecified
Closed: July, 2009
|
|
|
|
| Be the first to recommend Novast Pharmaceuticals!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
